Bazedoxifene was evaluated for its inhibitory effect on IL-6/GP130/STAT3 signaling in RH30, RD, and RH28 rhabdomyosarcoma cell lines expressing elevated P-STAT3 levels. The gene discussed is STAT3; the disease is rhabdomyosarcoma.